Forget glucose: what about lipids in critical illness?

Area of Science:

• Biochemistry
• Critical Care Medicine
• Pathophysiology

Background:

• High cholesterol is a known cardiovascular risk factor, but critically ill patients often show the opposite.
• Hypocholesterolemia (low cholesterol) in critical illness, especially sepsis, correlates with poorer patient outcomes.
• Changes in total cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides are common during critical illness.

Discussion:

• Lipid profile alterations may be a consequence of severe inflammation and sepsis.
• Biological mechanisms include lipoprotein interactions with endotoxins and cytokine regulation.
• The role of lipid alterations—whether causative or consequential—in organ dysfunction and infection susceptibility requires further study.

Key Insights:

• Decreased total and HDL cholesterol levels are associated with increased severity in critical illness.
• Lipid metabolism disturbances are significant in sepsis and critical care settings.
• Lipid emulsions are crucial for nutrition and drug delivery in critically ill patients.

Outlook:

• Further research into lipid metabolism alterations in critical illness is warranted.
• Investigating the impact of dietary lipid sources and amounts is essential.
• Therapeutic strategies targeting lipid profiles, using agents like statins or fibrates, may offer new treatment avenues for sepsis.